NCI is the nation's leader in cancer research
NCTN Navigator now includes pediatric data from the Children’s Oncology Group. Researchers may request specimens.
The network is the nation’s largest coordinated effort to study the immune response to COVID-19.
Not only is obesity associated with a higher risk of 13 types of cancer, it can also adversely affect cancer treatment and survival.
NCI supports many approaches to degrade proteins that drive cancer cell growth. One example is proteolysis targeting chimera (PROTAC).
NCI's RAS Initiative explores innovative approaches for attacking the proteins encoded by mutant forms of the KRAS gene.